Accéder au contenu
Merck
  • In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ

In vivo and in vitro ADMET profiling and in vivo pharmacodynamic investigations of a selective α7 nicotinic acetylcholine receptor agonist with a spirocyclic Δ

European journal of pharmacology (2017-12-25)
Carlo Matera, Giulio Dondio, Daniela Braida, Luisa Ponzoni, Marco De Amici, Mariaelvina Sala, Clelia Dallanoce
RÉSUMÉ

(±)-3-Methoxy-1-oxa-2,7-diaza-7,10-ethanospiro[4.5]dec-2-ene sesquifumarate (±)-1 was previously characterized as the most selective agonist at α7 neuronal nicotinic acetylcholine receptors in a series of spirocyclic quinuclidinyl-Δ

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
7-Methoxy-4-(trifluoromethyl)coumarin, ≥99% (TLC)